Pharmacological profile of 48740 R.P., a PAF-acether antagonist.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  European Journal of Pharmacology

• Publication date

  1988-06-10

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0014-2999(88)90006-4PMID 2843382
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In Vitro and In Vivo Pharmacological Profiles of the PAF Receptor Antagonist SRI 63-675

  1987cited by this paper
• Effects of WEB 2086, a novel antagonist of platelet activating factor, in active and passive anaphylaxis.

  1987cited by this paper
• Prevention of endotoxin-induced gastrointestinal damage by CV-3988, an antagonist of platelet-activating factor.

  1986cited by this paper
• Specific inhibition of PAF-acether-induced platelet activation by BN 52021 and comparison with the PAF-acether inhibitors kadsurenone and CV 3988.

  1986cited by this paper
• Interference of BN 52021 (ginkgolide B) with the bronchopulmonary effects of PAF-acether in the guinea-pig.

  1986cited by this paper
• Inhibition of the platelet activating factor (PAF)-induced in vivo responses in rats by trans-2,5-(3,4,5-trimethoxyphenyl) tetrahydrofuran (L-652,731), a PAF receptor antagonist.

  1986cited by this paper
• The anaphylactic release of platelet‐activating factor from perfused guinea‐pig lungs

  1986cited by this paper
• Interference of BN 52021, a PAF-acether antagonist, with endotoxin-induced hypotension in the guinea-pig.

  1986cited by this paper
• Inhibition of PAF-lnduced Systemic Responses in the Rat, Guinea Pig, Dog and Primate by the Receptor Antagonist SRI 63-441

  1986cited by this paper
• Specific binding of [3H]dihydrokadsurenone to rabbit platelet membranes and its inhibition by the receptor agonists and antagonists of platelet-activating factor.

  1986cited by this paper
• BN 52021 and related compounds: A new series of highly specific PAF-acether receptor antagonists isolated from Ginkgo biloba L.

  1985cited by this paper
• Pharmacology of the late response to allergen and its relevance to asthma prophylaxis.

  1985cited by this paper
• 48 740 R.P. : A specific paf-acether antagonist

  1985cited by this paper
• Characterization of a platelet-activating factor receptor antagonist isolated from haifenteng (Piper futokadsura): specific inhibition of in vitro and in vivo platelet-activating factor-induced effects.

  1985cited by this paper
• Ultrastructural evidence for extravascular platelet recruitment in the lung upon intravenous injection of platelet-activating factor (PAF-acether) to guinea-pigs.

  1985cited by this paper
• Desensitization to PAF-induced bronchoconstriction and to activation of alveolar macrophages by repeated inhalations of PAF in the guinea pig.

  1985cited by this paper
• The release of lyso-PAF from guinea-pig lungs.

  1985cited by this paper
• PAF: From agonists to antagonists by synthesis

  1985cited by this paper
• The effect of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (paf-acether) on the arterial wall.

  1985cited by this paper
• Is platelet activating factor (PAF) a mediator of endotoxin shock?

  1985cited by this paper
• Synthesis of PAF-acether and blood volume changes in gram-negative sepsis.

  1985cited by this paper
• Inhibition by ticlopidine of Paf-acether-induced in vitro aggregation of rabbit and human platelets.

  1984cited by this paper
• Platelet-activating factor-induced aggregation of human platelets specifically inhibited by triazolobenzodiazepines.

  1984cited by this paper
• Platelet‐activating factor: a possible mediator of the dual response to allergen?

  1984cited by this paper
• Biosynthesis of Paf-acether (platelet-activating factor). VII. Precursors of Paf-acether and acetyl-transferase activity in human leukocytes.

  1984cited by this paper
• The platelet‐independent release of thromboxane A2 by Paf‐acether from guinea‐pig lungs involves mechanisms distinct from those for leukotriene

  1984cited by this paper
• Acute circulatory collapse caused by platelet-activating factor (PAF-acether) in dogs.

  1983cited by this paper
• The release of platelet-activating factor from human endothelial cells in culture.

  1983cited by this paper
• CV-3988 - a specific antagonist of platelet activating factor (PAF).

  1983cited by this paper
• Mediators of immune-complex-induced aggregation of polymorphonuclear neutrophils. II. Platelet-activating factor as the effector substance of immune-induced aggregation.

  1981cited by this paper
• Human neutrophil-derived platelet activating factor.

  1980cited by this paper
• A simple and efficient method for platelet isolation from their plasma.

  1980cited by this paper
• Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives.

  1980cited by this paper
• Physicochemical and functional identity of rabbit platelet-activating factor (PAF) released in vivo during IgE anaphylaxis with PAF released in vitro from IgE sensitized basophils.

  1979cited by this paper
• The role of platelet-activating factor in platelet aggregation

  1979cited by this paper
• ROLE OF PLATELETS IN ASPIRIN‐SENSITIVE BRONCHOCONSTRICTION IN THE GUINEA‐PIG; INTERACTIONS WITH SALICYLIC ACID

  1978cited by this paper
• [Macrophage origin of platelet activating factor].

  1978cited by this paper
• Analytical methods for thromboxane B2 measurement and validation of radioimmunoassay by gas liquid chromatography-mass spectrometry.

  1978cited by this paper
• Intravascular aggregation and pulmonary sequestration of platelets during IgE-induced systemic anaphylaxis in the rabbit: abrogation of lethal anaphylactic shock by platelet depletion.

  1977cited by this paper
• IgE-induced release of a platelet-activating factor from rabbit lung.

  1975cited by this paper
• LEUKOCYTE-DEPENDENT HISTAMINE RELEASE FROM RABBIT PLATELETS

  1972cited by this paper
• Acetylsalicylic acid: inhibition of platelet aggregation in the rabbit.

  1971cited by this paper
• The microestimation of succinate and the extinction coefficient of cytochrome c.

  1959cited by this paper

• Inhibition of ex-vivo PAF-induced platelet aggregation by the PAF-antagonist RP 48740: relationship to plasma concentrations in healthy volunteers

  2004cites this paper
• Biosynthetic Inhibitors and Receptor Antagonists to Platelet Activating Factor

  1997cites this paper
• The role of PAF and the effect of a specific PAF antagonist on local tissue PO2 and neuronal integrity during and after photothrombotic brain infarction in unanesthetised rabbits.

  1996cites this paper
• PAF receptor antagonists in the treatment of asthma

  1994cites this paper
• Platelet-activating factor and interleukin 1 are involved in colonic dysmotility in experimental colitis in rats.

  1993cites this paper
• [Effects of PAF antagonists in experimental models. Therapeutical perspectives].

  1993cites this paper
• Compound PCA-4248 interferes with bronchopulmonary anaphylaxis and with in vitro hyperresponsiveness to platelet-activating factor.

  1993cites this paper
• Biochemical pharmacology of platelet-activating factor (and PAF antagonists) in relation to clinical and experimental thrombocytopenia.

  1991cites this paper
• Inhibitory effects of a platelet activating factor-antagonist 48740RP in cyclosporin-induced nephrotoxicity in the rat as assessed by renal glutathione metabolism parameters.

  1991cites this paper
• Thromboxane receptor activation during bronchospasm induced by platelet-activating factor.

  1991cites this paper
• A comparative study on the activation of J-774 macrophage-like cells by gamma-interferon, 1,25-dihydroxyvitamin D3 and lipopeptide RP-56142: ability to kill intracellularly multiplying Mycobacterium tuberculosis and Mycobacterium avium.

  1990cites this paper
• [Inhibitory effects of OKY-046.HCl, a selective thromboxane (TX) A2 synthetase inhibitor, on platelet activating factor (PAF)-induced airway hyperresponsiveness in guinea pigs].

  1990cites this paper
• Platelet-Activating-Factor(PAF)吸入誘発モルモット気道過敏性に対する特異的Thromboxane A2合成酵素阻害剤(E)-3-〔p-(1H-imidazol-1-ylmethyl)phenyl〕-2-propenoic acid hydrochloride monohydrate (OKY-C)46・HCl)の抑制作用

  1990cites this paper
• Preclinical and clinical pharmacology of platelet‐activating factor receptor antagonists

  1990cites this paper
• PROLONGED SURVIVAL OF RENAL TRANSPLANTS IN NONIMMUNIZED AND HYPERIMMUNIZED RATS RECEIVING A PLATELET‐ACTIVATING FACTOR ANTAGONIST

  1990cites this paper
• Pharmacological modulation of Paf‐induced rat pleurisy and its role in inflammation by zymosan

  1989cites this paper
• Pharmacological modulation ofPaf-induced rat pleurisy andits role ininflammation byzymosan

  1989cites this paper
• The role of platelet activating factor in allergic inflammation.

  1989cites this paper
• New Pharmacological Agents Which Antagonize Leukotriene D4 and Platelet Activating Factor

  1989cites this paper
• 48740 RP, an antagonist of PAF, does not affect human plasma fibrinolysis before and after venous occlusion.

  1988cites this paper